Leah Kuntz

FDA Accepts NDA for TRN-257 for Treatment of Narcolepsy and Idiopathic Hypersomnia

This Giving Tuesday, Give Back to Psychiatry: Places to Donate

November in Review: Updates on the Psychiatric Treatment Pipeline

Vagus Nerve Stimulation in Treatment Resistant Depression: New Lines of Thinking

Benefits of Long-Acting Injectable Antipsychotics: An Overview From Southern Florida Psychiatry Conference

Prescription Digital Therapeutics: Transforming Health Care Delivery

Planned FDA Investigational New Drug Application: SPC-15 for the Treatment of PTSD

FDA Clears Deep Transcranial Magnetic Stimulation for Adolescents With MDD

Everything You Need to Know About the Approval of Lumateperone for Major Depressive Disorder

A “Surprise” Miss: NBI-1070770 for Major Depressive Disorder Fails in Phase 2 Study